Article
Grazoprevir/elbasvir for the immediate treatment of recently acquired HCV genotype 1 or 4 infection in MSM.
The Journal of antimicrobial chemotherapy - 1 Jul 2020
Boyd Anders, Miailhes Patrick, Chas Julie, Valantin Marc-Antoine, Yazdanpanah Yazdan, Rosenthal Eric, Chevaliez Stephane, Piroth Lionel, Rougier Hayette, Peytavin Gilles, Pialoux Gilles, Girard Pierre-Marie, Lacombe Karine
Abstract excerpt
BACKGROUND: In Europe, increases in HCV infection have been observed over the last two decades in MSM, making them a key population for recently acquired HCV. Alternative combinations of direct-acting antiviral agents against early HCV infection need to be assessed. PATIENTS AND METHODS: In this pilot trial, MSM with recently acquired genotype 1 or 4 HCV infection were prospectively included and received 8 weeks...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.